Italy's prestigious Veneto Institute of Oncology acquires MILabs' latest VECTor5CT system

The Istituto Oncologico Veneto (IOV) has acquired MILabs’ latest generation VECTor5CT as a key imaging tool to support its translational oncology mission, entrusted by the Italian Ministry of Health and the Organization of the European Cancer Institutes. Due to its high-resolution imaging capabilities, MILabs’ preclinical Versatile Emission Computed Tomography system (“VECTor”) is very well suited to enable a quick translation of molecular research from the bench to the clinic at the IOV.

According to Prof. Antonio Rosato, Deputy Scientific Director and in charge of the preclinical imaging facility of the Institute:

We anticipate that the unique ability of the MILabs system to image tumors with high-definition PET, SPECT and CT modalities, further enhanced by high-resolution imaging of radiotherapeutic tracers such as 188Re, will accelerate IOV’s research on the personalization of therapy in solid tumors.

Prof. Freek Beekman, CEO/CSO of MILabs B.V. adds:

We are confident that the unique diagnostic and theranostic imaging capabilities of the VECTor5CT will help IOV-IRCCS stay at the leading edge of bringing the latest scientific findings from the laboratory to the patient so it can keep offering the most innovative therapies.

By integrating multiple modalities on a single system, MILabs’ VECTor PET/SPECT/CT enables to expand diagnostic and treatment applications beyond the capabilities of any other preclinical imaging system including single-pass simultaneous PET and SPECT, dynamic molecular CT acquisitions as well as theranostic imaging with alpha- and beta- radiotherapy nuclides.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    MILabs. (2019, June 19). Italy's prestigious Veneto Institute of Oncology acquires MILabs' latest VECTor5CT system. News-Medical. Retrieved on November 22, 2019 from https://www.news-medical.net/news/20180425/Italys-prestigious-Veneto-Institute-of-Oncology-acquires-MILabs-latest-VECTor5CT-system.aspx.

  • MLA

    MILabs. "Italy's prestigious Veneto Institute of Oncology acquires MILabs' latest VECTor5CT system". News-Medical. 22 November 2019. <https://www.news-medical.net/news/20180425/Italys-prestigious-Veneto-Institute-of-Oncology-acquires-MILabs-latest-VECTor5CT-system.aspx>.

  • Chicago

    MILabs. "Italy's prestigious Veneto Institute of Oncology acquires MILabs' latest VECTor5CT system". News-Medical. https://www.news-medical.net/news/20180425/Italys-prestigious-Veneto-Institute-of-Oncology-acquires-MILabs-latest-VECTor5CT-system.aspx. (accessed November 22, 2019).

  • Harvard

    MILabs. 2019. Italy's prestigious Veneto Institute of Oncology acquires MILabs' latest VECTor5CT system. News-Medical, viewed 22 November 2019, https://www.news-medical.net/news/20180425/Italys-prestigious-Veneto-Institute-of-Oncology-acquires-MILabs-latest-VECTor5CT-system.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Queen Mary University of London’s BCI boosts radionuclide imaging capabilities with MILabs VECTor technology